During the past decade, Hôpital Cardiologique conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 10 clinical trials were completed, i.e. on average, 52.6% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 7 clinical trials were completed. i.e. 116.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hôpital Cardiologique" #1 sponsor was "Actelion" with 6 trials, followed by "University Hospital, Lille" with 4 trials sponsored, "Abbott Medical Devices" with 3 trials sponsored, "Assistance Publique - Hôpitaux de Paris" with 2 trials sponsored and "Baxalta now part of Shire" with 2 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Cardiologique" #1 collaborator was "Fondation de Recherche sur l'Hypertension Artérielle" with 2 trials as a collaborator, "Takeda Development Center Americas, Inc." with 2 trials as a collaborator, "Baxalta Innovations GmbH, now part of Shire" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator and "CRI-The Clinical Research Institute GmbH" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Cardiologique" are "Pulmonary Arterial Hypertension" (5 trials), "Coronary Artery Disease" (4 trials), "Hypertension, Pulmonary" (4 trials), "Heart Failure" (3 trials) and "Aortic Aneurysm, Abdominal" (2 trials). Many other conditions were trialed in "Hôpital Cardiologique" in a lesser frequency.

Most popular intervention types in "Hôpital Cardiologique" are "Drug" (12 trials), "Device" (11 trials), "Biological" (4 trials), "Other" (4 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Macitentan" (4 trials), "Antihemophilic Factor (Recombinant)" (2 trials), "Ralinepag" (2 trials) and "von Willebrand factor (Recombinant)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Cardiologique" are 38 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hôpital Cardiologique". undefined are not yet recruiting, 8 are recruiting, 1 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 20 completed trials in Hôpital Cardiologique, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Cardiologique, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 9 trials that are defined as “Not Applicable".